Unlock instant, AI-driven research and patent intelligence for your innovation.

Proteinase inhibitor nervous cell protecting function and application

A protease inhibitor and excipient technology, applied in the field of Kunitz-type protease inhibitors

Inactive Publication Date: 2008-03-19
吉林圣元科技有限责任公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, so far, there have been no reports about the protective function of KD / APP on nerve cells and its use in the prevention and treatment of neurological injury diseases caused by cerebral ischemia caused by various reasons.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Proteinase inhibitor nervous cell protecting function and application
  • Proteinase inhibitor nervous cell protecting function and application
  • Proteinase inhibitor nervous cell protecting function and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1: Preparation of rat model of acute cerebral infarction, animal grouping, experimental method and result evaluation method

[0052] 1. Preparation of animal (rat) cerebral ischemia-reperfusion injury model: refer to Zealonga suture method (LongaEZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral arteryocclusion without craniectomy in rats. Stroke, 1989, 20 (1) : 8491.) To prepare the focal cerebral ischemia-reperfusion model of right middle cerebral artery occlusion (MCAO) in rats. A 6.0 cardiac surgery single-strand nylon thread (length 4cm, diameter 0.235mm) was used as the tethered thread. One end of the thread was blunted with fire to make the diameter of the top 0.26-0.32mm, and a mark was made at a distance of 18mm from the end. After cleaning with alcohol, put it in 1% sodium heparin for later use.

[0053] Rats were fasted without food or water for 12 hours before the operation. Anesthetized by intraperitoneal injection of 10% chloral hydra...

Embodiment 2

[0076] Example 2: Effects of rhKD / APP on neurological function in rats with cerebral ischemia-reperfusion injury:

[0077] Rat cerebral ischemia model was prepared by MCAO method. After 3 hours of ischemia and 24 hours of reperfusion, obvious neurological deficits were observed in the model group, and the mortality rate was as high as 26.5%. Compared with the model group, the neurological deficits of animals given the neuroprotective drug Nimodi pine (positive control group) were significantly improved (P<0.05), but the mortality rate was still high (P<0.05). Compared with the model group, the neurological deficits of animals in the rhKD / APP low, middle and high dose groups were also significantly improved (P<0.01); and with the increase of the dose, the neurological function score improved significantly. However, there was no statistically significant difference among the three dose groups. Compared with the model group, the mortality rate of animals treated with low, mediu...

Embodiment 3

[0081] Example 3: Effects of rhKD / APP on cerebral infarction size in acute cerebral infarction model:

[0082]TTC is a water-soluble salt, which can react with the dehydrogenase in the mitochondria of cells to produce dark red fat-soluble substances. Dead cells do not develop color due to the inactivation of mitochondrial dehydrogenase. method. In this study, the TTC staining method was used to observe and calculate the cerebral infarction range of each group after 3 hours of cerebral ischemia and 24 hours of reperfusion (see Table 2). Compared with the model group, the cerebral infarction area in the middle and high dose rhKD / APP group and Nimodipine group was significantly reduced (p<0.05). The size of cerebral infarction in the high-dose rhKD / APP group was significantly lower than that in the model group (P<0.01), and there was an obvious dose-related relationship (see Figure 3).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to a Kunitz type protease inhibitor (KD / APP) and the preparation method and application of the Kunitz type protease inhibitor and in particular to the brain cell protective function of a recombinant human Kunitz type protease inhibitor and the application in the production of the drug for preventing and remedying the relevant diseases of the cecebral ischemia-reperfusion injury. The invention further relates to a drug combination which consists of the Kunitz type protease inhibitor which is used as basic active component and one kind or a plurality of kinds of carriers or excipients which are medically acceptable.

Description

field of invention [0001] The present invention relates to a Kunitz-type protease inhibitor (KD / APP, trade name Amykunin), in particular to the nerve cell protection function of KD / APP, and its application in the production of medicines for preventing and treating nerve damage diseases. Background of the invention [0002] BPTI is an alkaline silk protease inhibitor with broad-spectrum protease inhibitory activity. Clinically, it is mainly used to reduce hemorrhage and inflammatory response after surgery. But BPTI is a heterologous protein, which is immunogenic. Repeated use in large quantities or for a long time may cause allergic reactions. Therefore, it is necessary to find a BPTI of human origin, small molecular weight, and strong inhibitory activity. The β-amyloid precursor (APP) contains a Kunitz-type domain (Kunitz domain, KD), and the APP gene is located on the human chromosome 21. The proximal region of the arm (21q21.2), in which the KD region in the APP protein...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/57A61P9/10A61P1/16
Inventor 颜炜群王冰贺巾超杨莉莉马杰
Owner 吉林圣元科技有限责任公司